Swallowing disorders and mortality in adults with advanced cancer outside the head and neck and upper gastrointestinal tract: a systematic review

被引:3
作者
Silva, Danielle Nunes Moura [1 ]
Vicente, Laelia Cristina Caseiro [1 ]
Gloria, Vanessa Lais Pontes [2 ]
Friche, Amelia Augusta de Lima [1 ]
机构
[1] Univ Fed Minas Gerais UFMG, Fac Med, Posgrad Ciencias Fonoaudiol, 190 Alfredo Balena Ave, BR-30130100 Belo Horizonte, MG, Brazil
[2] IPSEMG Hosp, Inst Previdencia Servidores Estado Minas Gerais IP, 225 Alameda Ezequiel Dias, BR-30130110 Belo Horizonte, MG, Brazil
关键词
Deglutition disorders; Neoplasms; Prognosis; Survival; Palliative care; Systematic review; QUALITY-OF-LIFE; LUNG-CANCER; CONCURRENT CHEMORADIOTHERAPY; PROGNOSTIC INDICATORS; PREDICT SURVIVAL; CARE; RADIOTHERAPY; PHASE; DYSPHAGIA; SYMPTOMS;
D O I
10.1186/s12904-023-01268-4
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundAlthough oncological palliative care is increasingly being offered by multidisciplinary teams, there is still a lack of data about some symptoms handled by these teams, such as dysphagia, in patients with advanced cancer outside swallow regions. This study aimed to estimate the occurrence of dysphagia in prognosis studies of adults with advanced cancer outside the head, neck, and upper gastrointestinal tract, and to determine if there is an association with mortality.MethodsA systematic review of studies that evaluated dysphagia and mortality was conducted (PROSPERO: CRD42021257172).Data sourcesBVS, PubMed, CINAHL, Web of Science, and Scopus. Data between 2011 and 2023 were selected.ResultsAmong the 608 articles screened, only 14 were included, which covered different types of cancer, primarily Lung, and Genitourinary, Skin, Hematological, and Central Nervous System as well. Dysphagia demonstrated a variable frequency, and almost half of the studies found a percentage of dysphagia above 60%, appearing most as a symptom that affects health-related quality of life and prove to be a toxicity of treatment. The association between dysphagia and mortality was only evaluated in three articles that studied advanced lung cancer, in which, after controlling for covariates, swallowing disorders were associated with worse survival, with prevalences of dysphagia and hazard ratios of 78.5% (1.12 [1.04-1.20]), 4% (1.34 [1.28-1.35]), and 3% (1.40 [1.07-1.81]), respectively.ConclusionsThe occurrence of dysphagia in advanced cancer outside the head, neck, and upper GI tract is common, and there seems to be an association with significantly decreased survival in patients with advanced lung cancer.
引用
收藏
页数:13
相关论文
共 40 条
  • [1] Survival and late toxicities following concurrent chemo-radiotherapy for locally advanced stage III non-small cell lung cancer: findings of a 10-year Australian single centre experience with long term clinical follow up
    Abbas, M. Nazim
    Ayoola, Adeola
    Padman, Sunita
    Kumar, Rajiv
    Leung, John
    Ullah, Shahid
    Koczwara, Bogda
    Sukumaran, Shawgi
    Kichenadasse, Ganessan
    Roy, Amitesh
    Richards, Alison M.
    Bowden, Jeffrey J.
    Karapetis, Christos S.
    [J]. JOURNAL OF THORACIC DISEASE, 2019, 11 (10) : 4241 - 4248
  • [2] Ansari M, 2014, IRAN J MED SCI, V39, P341
  • [3] Tolerability of sequential immune therapy and palliative radiotherapy to the cervical and thoracic spine
    Arscott, W. Tristram
    Doucette, Abigail
    Kumar, Pallavi
    Plastaras, John P.
    Maity, Amit
    Jones, Joshua
    [J]. JOURNAL OF RADIATION ONCOLOGY, 2018, 7 (03) : 233 - 239
  • [4] Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
    Bradley, Jeffrey D.
    Paulus, Rebecca
    Komaki, Ritsuko
    Masters, Gregory
    Blumenschein, George
    Schild, Steven
    Bogart, Jeffrey
    Hu, Chen
    Forster, Kenneth
    Magliocco, Anthony
    Kavadi, Vivek
    Garces, Yolanda I.
    Narayan, Samir
    Iyengar, Puneeth
    Robinson, Cliff
    Wynn, Raymond B.
    Koprowski, Christopher
    Meng, Joanne
    Beitler, Jonathan
    Gaur, Rakesh
    Curran, Walter, Jr.
    Choy, Hak
    [J]. LANCET ONCOLOGY, 2015, 16 (02) : 187 - 199
  • [5] Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer?
    Braun, Donald P.
    Gupta, Digant
    Grutsch, James F.
    Staren, Edgar D.
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2011, 9
  • [6] Withdrawal of anticancer therapy in advanced disease: a systematic literature review
    Clarke, G.
    Johnston, S.
    Corrie, P.
    Kuhn, I.
    Barclay, S.
    [J]. BMC CANCER, 2015, 15
  • [7] Palliative and supportive care in head and neck cancer: United Kingdom National Multidisciplinary Guidelines
    Cocks, H.
    Ah-See, K.
    Capel, M.
    Taylor, P.
    [J]. JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2016, 130 : S198 - S207
  • [8] Deglutition disorders as a consequence of head and neck cancer therapies: a systematic review and meta-analysis
    de Toledo, Isabela Porto
    Quirino Pantoja, Leticia Lopes
    Luchesi, Karen Fontes
    Assad, Daniele Xavier
    Canto, Graziela De Luca
    Silva Guerra, Eliete Neves
    [J]. SUPPORTIVE CARE IN CANCER, 2019, 27 (10) : 3681 - 3700
  • [9] Ecog ACRIN, 2012, ECOG Performance Status
  • [10] Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial
    Ediebah, D. E.
    Coens, C.
    Zikos, E.
    Quinten, C.
    Ringash, J.
    King, M. T.
    von Koch, J. Schmucker
    Gotay, C.
    Greimel, E.
    Flechtner, H.
    Weis, J.
    Reeve, B. B.
    Smit, E. F.
    Taphoorn, M. J. B.
    Bottomley, A.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 110 (10) : 2427 - 2433